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Resveratrol is a promising therapeutic capable of altering melanoma growth and 
metastasis at least partially through its interactions with the androgen receptor signaling 
pathway. Future studies should examine the effects of resveratrol on melanoma that has 
not metastasized yet to further characterize its ability to prevent metastasis. Additional in 
vivo studies examining its effects on melanoma through innovative methods of delivery 
will be useful in bringing resveratrol from bench to bedside.
Conclusion
Although melanoma affects both sexes, current literature shows it is more prevalent 
and more deadly in men. The androgen receptor has been proven to play a role in 
melanoma growth and metastasis, and may play a part in the difference in incidence 
and mortality rates between sexes. Resveratrol, a naturally occurring compound with 
poor bioavailability, has been shown to decrease melanoma cell growth in both in vitro 
and in vivo studies and has known effects on the androgen receptor signaling pathway. 
We propose that resveratrol is a potential therapeutic that can decrease melanoma 
growth and invasion by targeting the androgen receptor pathway, and we review 
current and future perspectives for resveratrol application methods. 
Introduction
Cell culturing: A375-MA2 metastatic melanoma cells were maintained according to 
American Type Culture Collection (ATCC) protocol. 
Western Blotting: 50 µg of each protein sample were run through SDS-PAGE and 
transferred to nitrocellulose for blotting. Western blots were performed for Ubiquitin-
conjugating enzyme E2 C (UBE2C), androgen receptor (AR), E-Cadherin (CDH1), N-
Cadherin (CHD2), and β-Tubulin. (Figure 1)
Scratch Wound Assay: Five separate 10 cm plates of melanoma cells were sub-
cultured. After they reached total confluency they were washed with PBS two times, 
scratched with a pipette tip, and immediately bathed in medium containing varying 
concentrations of RSV. Pictures were taken at 0, 6, 12, 18, and 24 hours. (Figure 2)
RNA Extraction and qPCR: RNA isolation from the cultured cells was performed using 
the QIAGEN RNeasy kit and quantified with a Nanodrop 2000. cDNA was synthesized 
and gene expression was measured using StepOnePlus Real Time PCR System. 
Taqman probes CDH1, CDH2, UBE2C, and CCAR2 were utilized as AR activity 
indicators. All samples were done in quadruplicate. (Figure 3)
Methods
Figure 2. Migration of Melanoma Cells in Scratch Wound Assay. A dose-
dependent decrease in melanoma migration was visualized with increasing 
concentrations of RSV. The untreated plate almost reached total confluency 24 
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Figure 3. Relative mRNA Expression. No difference in cadherin or CCAR2 
expression  was visualized. There was a dose-dependent decrease in UBE2C 
expression with increasing RSV treatment. 
Western Blot Results
Figure 1. Protein 
Levels. Protein 
samples from MA-2 
cells treated with RSV 
were analyzed via 
Western Blot for 
UBE2C, AR, CDH1, 
and CDH2. Western 
blots were treated with 
β-Tubulin to control for 
loading. 
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Bench to Bedside
Problem: Resveratrol is lipophilic and has poor bioavailability due to high rates of first 
pass metabolism by the liver, intestines, and intestinal bacteria. 
Potential Solutions: Topical application with solid lipid nanoparticles, nanostructured 
lipid carriers, prodrugs.
Resveratrol Resveratrol Trimesylate
